Physician

Ilija Aleksic, M.D.

According to 2025 Medicare claims, Ilija Aleksic, M.D. (NPI: 1962820977) practices urology in the Syracuse, NY market, with the plurality of this provider's patient population coming from Onondaga, NY. This provider's primary affiliated billing organization is ASSOCIATED MEDICAL PROFESSIONALS OF NY, PLLC (NPI: 1467659060; TIN: 208928235) and primary practice location at 13210-1155.

Aleksic's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 739 traditional Medicare patients, billed 9,799 HCPCS/CPT codes, and received $544,544 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 844 prescription claims across 268 beneficiaries totaling $49,436 in drug costs, led by Gemtesa (Vibegron). DME data shows 17 claims. Open Payments data shows 84 records totaling $7,106. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $34,316 to $544,544. Similarly, Part D prescription costs have risen steadily, from $1,295 to $49,436. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	163	2,148	$34,316
2020	515	8,609	$163,369
2021	655	11,878	$117,908
2022	917	14,341	$196,496
2023	813	13,734	$316,270
2024	739	9,799	$544,544

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	26	51	$1,295
2016	67	102	$2,644
2017	25	50	$1,297
2018	25	40	$986
2019	50	84	$3,086
2020	181	443	$38,619
2021	215	616	$43,516
2022	283	763	$70,074
2023	330	887	$80,169
2024	268	844	$49,436

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	28	$3,847
2023	N/R	50	$12,615
2024	N/R	17	$2,651

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	188	256	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	143	152	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	167	185	$12
36415	Insertion of needle into vein for collection of blood sample	141	163	$8
81003	Automated urinalysis test	296	376	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gemtesa	Vibegron	24	1,420	$22,273
Tamsulosin Hcl	Tamsulosin Hcl	292	20,246	$3,618
Fesoterodine Fumarate Er	Fesoterodine Fumarate	12	360	$1,928
Estradiol	Estradiol	18	2,236	$1,914
Solifenacin Succinate	Solifenacin Succinate	68	2,220	$1,469

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	17	$2,651

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	84	$7,106	Ferring Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ilija Aleksic, M.D.?

Tedicare shows public-source Medicare data for Ilija Aleksic, M.D. (NPI 1962820977), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ilija Aleksic, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ilija Aleksic, M.D.?

Ilija Aleksic, M.D. is linked to ASSOCIATED MEDICAL PROFESSIONALS OF NY, PLLC (billing NPI 1467659060) in the available physician profile data.

Does Ilija Aleksic, M.D. have Open Payments data?

Ilija Aleksic, M.D. has 84 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.